Vancomycin, long a last line of defence against hospital superbugs, is losing its power as resistant bacteria spread. Now researchers have found a small molecule that can restore its punch against vancomycin-resistant Enterococcus faecium, offering a fresh route to tackling one of medicine’s most stubborn antimicrobial resistance problems.
A Madison-based team has stripped liquid chromatography out of peptide mapping, the workhorse test drug developers use to check whether antibody therapeutics have degraded. The new method, described in a bioRxiv preprint and now spun out as the company CeleramAb, promises to turn a nine-day analysis into a matter of hours.
Warwick and Verdel Instruments researchers have shown that two-dimensional mass spectrometry, previously the preserve of scarce, expensive FT-ICR instruments, can now be performed on a common benchtop quadrupole time-of-flight machine, potentially letting ordinary clinical and research laboratories skip chromatography altogether while pulling more information from complex mixtures.
CellCarta, a global contract research organisation (CRO) laboratory serving the biopharmaceutical industry, has announced the formation of a Digital Pathology and AI Consortium intended to support biomarker discovery, patient stratification and companion diagnostic development across multiple disease areas.
Novogene Europe has expanded its single-cell RNA sequencing capability at its Cambridge Omics Centre, extending workflows built around the 10x Genomics Chromium platform to academic, biotech and biopharma researchers across the UK.
BioMed X, an innovation engine for pharmaceutical research and development based in New Haven, Connecticut, has announced a global call for research proposals focused on neural circuit regulation of immune function. The initiative, supported by Biogen, invites researchers worldwide to submit original concepts examining the relationship between the nervous system and the immune system, with […]
Elevara Medicines, a clinical-stage company developing therapies for rheumatoid arthritis (RA) and other chronic inflammatory conditions, has announced the appointment of Mai-Britt Zocca, PhD, as Chief Executive Officer, effective 1 July 2026. Dr Zocca succeeds founder Emma Tinsley, who will remain with the company as a Non-Executive Director on the Board.
ELRIG, the Cambridge-based not-for-profit, volunteer-led organisation serving the global drug discovery community, has appointed Dr Hitesh Sanganee and Dr Marcus Schindler to its Scientific Advisory Board (SAB).
Navigo Proteins has announced the appointment of Dr Florian Settele as Managing Director of Navigo Pure, its wholly owned subsidiary specialising in downstream bioprocessing.
Autolomous and Cellular Origins have announced integration of their respective platforms, bringing automation and digitisation to the cell therapy manufacturing process. The combined approach establishes a connected manufacturing environment intended to give developers greater standardisation, traceability and control across the manufacturing pathway.
August 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.